Clinical Trials Browser

Phase 3 × NETWORK × palbociclib × Clear all

NCT03820830 2026-04-09

POLAR

Phase 3 Active not recruiting

Breast Cancer Recurrent

NCT03425838 2025-09-19

Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Phase 3 Active not recruiting

Breast Neoplasm Female